Re: One year perspective on COURAGE

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 3, 2009, Pages 428-

  Sedlis, Steven P ^a   Boden, William E ^a   Weintraub, William S ^a   Maron, David S ^a   O'Rourke, Robert A ^a   Berman, Daniel S ^a   Mancini, G B John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; LETTER; MEDICAL RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTOR; RISK REDUCTION; STABLE ANGINA PECTORIS; TREATMENT FAILURE;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ARTERY DISEASE; HUMANS; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME;

EID: 65549108459     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21848     Document Type: Letter

References (3)

1. Tommaso CL. One year perspective on COURAGE. Catheter Cardiovasc Interv 2008;72:426-429.
2. Boden WE, O'Rourke RA, Teo KK, et al.; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary artery disease. N Engl J Med 2007;356:1503-1516.
3. Shaw LJ, Berman DS, Maron DJ, et al.; COURAGE Investigators. Optimal medical therapy with or without percutaneous intervention to reduce ischemic burden: Results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-1291.